BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10081842)

  • 1. Frequency of urolithiasis in individuals seropositive for human immunodeficiency virus treated with indinavir is higher than previously assumed.
    Reiter WJ; Schön-Pernerstorfer H; Dorfinger K; Hofbauer J; Marberger M
    J Urol; 1999 Apr; 161(4):1082-4. PubMed ID: 10081842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protease inhibitor-induced urolithiasis.
    Gentle DL; Stoller ML; Jarrett TW; Ward JF; Geib KS; Wood AF
    Urology; 1997 Oct; 50(4):508-11. PubMed ID: 9338723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of complicated renal colic in patients treated with indinavir: value of double J stents].
    Van Glabeke E; Conort P; Chartier-Kastler E; Desrez G; Boyer C; Richard F
    Prog Urol; 1999 Jun; 9(3):470-3. PubMed ID: 10434319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyuria in patients treated with indinavir is associated with renal dysfunction.
    Sarcletti M; Petter A; Romani N; Lhotta K; König P; Maier H; Zangerle R
    Clin Nephrol; 2000 Oct; 54(4):261-70. PubMed ID: 11076101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urolithiasis associated with the protease inhibitor indinavir.
    Bruce RG; Munch LC; Hoven AD; Jerauld RS; Greenburg R; Porter WH; Rutter PW
    Urology; 1997 Oct; 50(4):513-8. PubMed ID: 9338724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective study of urinalysis abnormalities in HIV-positive individuals treated with indinavir.
    Gagnon RF; Tecimer SN; Watters AK; Tsoukas CM
    Am J Kidney Dis; 2000 Sep; 36(3):507-15. PubMed ID: 10977782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased incidence of indinavir nephrolithiasis in patients with hepatitis B or C virus infection.
    Malavaud B; Dinh B; Bonnet E; Izopet J; Payen JL; Marchou B
    Antivir Ther; 2000 Mar; 5(1):3-5. PubMed ID: 10846585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased prevalence and analysis of risk factors for indinavir nephrolithiasis.
    Saltel E; Angel JB; Futter NG; Walsh WG; O'Rourke K; Mahoney JE
    J Urol; 2000 Dec; 164(6):1895-7. PubMed ID: 11061951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protease inhibitors and urolithiasis.
    Sutherland SE; Reigle MD; Seftel AD; Resnick MI
    J Urol; 1997 Jul; 158(1):31-3. PubMed ID: 9186316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nephrolithiasis in a HIV infected patient treated with indinavir].
    Brzósko S; Hryszko T; Panasiuk B; Prokopowicz D; Myśliwiec M
    Przegl Lek; 2001; 58(6):528-9. PubMed ID: 11816748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indinavir urolithiasis: an emerging cause of renal colic in patients with human immunodeficiency virus.
    Kohan AD; Armenakas NA; Fracchia JA
    J Urol; 1999 Jun; 161(6):1765-8. PubMed ID: 10332431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Urinary lithiasis secondary to indinavir in an HIV-positive patient].
    Moyano Calvo JL; Huesa Martínez I; Cruz Navarro N; Leal Arenas J; León Dueñas E; Morales López A; Maestro Durán JL; Ramírez Mendoza A
    Arch Esp Urol; 2001 Dec; 54(10):1117-20. PubMed ID: 11852520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of environmental temperature on incidence of indinavir-related nephrolithiasis.
    Martínez E; Leguizamón M; Mallolas J; Miró JM; Gatell JM
    Clin Infect Dis; 1999 Aug; 29(2):422-5. PubMed ID: 10476752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging characteristics of indinavir calculi.
    Schwartz BF; Schenkman N; Armenakas NA; Stoller ML
    J Urol; 1999 Apr; 161(4):1085-7. PubMed ID: 10081843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A once-daily HAART regimen containing indinavir + ritonavir plus one or two nucleoside reverse transcriptase inhibitors (PIPO study).
    Burger DM; Aarnoutse RE; Dieleman JP; Gyssens IC; Nouwen J; de Marie S; Koopmans PP; Stek M; van der Ende ME
    Antivir Ther; 2003 Oct; 8(5):455-61. PubMed ID: 14640393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Three patients with indinavir-related urolithiasis].
    Brandenburg JJ; Hoepelman IM; Stapper G; Lock MT
    Ned Tijdschr Geneeskd; 2007 Aug; 151(33):1839-45. PubMed ID: 17874643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The etiology of urolithiasis in HIV infected patients.
    Nadler RB; Rubenstein JN; Eggener SE; Loor MM; Smith ND
    J Urol; 2003 Feb; 169(2):475-7. PubMed ID: 12544290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anuria in HIV+ patients treated with indinavir].
    Rebassa Llull MJ; Conte Visús A; Grases Freixedas F; Muñoz Vélez D; Mus Malleu A; Torrens Darder I; Sanz-Gadea CG; Ozonas Moragues M
    Arch Esp Urol; 2000 Oct; 53(8):719-21. PubMed ID: 11126974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nephritic colic due to indinavir].
    Hermieu JF; Prévot MH; Ravery V; Moulinier F; Delmas V; Bouvet E; Boccon-Gibod L
    Presse Med; 1998 Mar; 27(10):465-7. PubMed ID: 9767973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can Phyllanthus niruri affect the efficacy of extracorporeal shock wave lithotripsy for renal stones? A randomized, prospective, long-term study.
    Micali S; Sighinolfi MC; Celia A; De Stefani S; Grande M; Cicero AF; Bianchi G
    J Urol; 2006 Sep; 176(3):1020-2. PubMed ID: 16890682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.